In conclusion, this is the first clinical study to demonstrate that serum ISM1 levels are significantly reduced in RA patients and independently associated with disease activity, as measured using DAS28-CRP and DAS28-ESR, after adjustment for key inflammatory and demographic variables. Here, CRP is linked to rheumatoid arthritis.